Author

Marina Savinova

Observed names: M. Savinova, M. T. Savinova, Marina T Savinova, М. Т. Савинова, М.Т. Савинова, Савинова М.Т.

ORCID: 0009-0004-1982-6109

Observed ORCID: 0009-0004-1982-6109

OpenAlex ID: A5033601554

Multiple Myeloma in Russia (First Results of the Registration Trial)

2017 · Л. П. Менделеева, Maxim Solovev, et al. · Blood · 5

Immune thrombocytopenia: clinical manifestation and therapy response. The interim analysis of Russian register of patients with primary immune thrombocytopenia and literature review

2014 · I. A. Lisukov, A. A. Maschan, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 4

Incidence of Primary Immune Thrombocytopenia (ITP) in Adults in One Region of Russia

2016 · Anait L. Melikyan, Elena I Pustovaya, et al. · Blood · 3

Epidemiological and clinical features of multiple myeloma in Russia: results of a multicenter prospective study

2026 · M. V. Solovev, L. P. Mendeleeva, et al. · MD-Onco · 2

Quality of Life and Efficacy of Triplet IxaRd Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Multi-Center Pilot Real-World Study

2022 · T. I. Ionova, O. Yu. Vinogradova, et al. · Clinical oncohematology · 2

The Impact of Circulating Plasma Cells on Overall Survival (OS) in Patients with Newly Diagnosed Multiple Myeloma (MM) - Results of a Multicenter Study

2024 · Maksim V Soloviev, Larisa Mendeleeva, et al. · Blood · 1

Pb2021: Quality of Life and Clinical Outcomes in Patients With Relapsed/refractory Multiple Myeloma (rrmm) Treated With Ixazomib-lenalidomide-dexamethasone (ird): Results of a Real-world Evidence Study

2022 · T. Ionova, O. Vinogradova, et al. · HemaSphere · 1

Оценка цитогенетического риска у пациентов с вновь диагностированной множественной миеломой по данным проспективного наблюдательного российского исследования

2026 · М.В. Соловьев, Л.П. Менделеева, et al. · Гематология Трансфузиология Восточная Европа

Analysis of one-year survival and mortality structure of patients with MM according to data from a multicenter Russian prospective study

2026 · M. V. Solovev, L. P. Mendeleeva, et al. · Гематология и трансфузиология

Incidence and Prognostic Value of Bone and Extramedullary Plasmacytomas in Patients with Newly Diagnosed Multiple Myeloma: Data from a Prospective Population-Based Study

2026 · Maksim Valerevich Solovev, L. P. Mendeleeva, et al. · Clinical oncohematology

Quality of Life (QoL) and Clinical Outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Ixazomib-Lenalidomide-Dexamethasone (IRd) in a Real-World Setting

2020 · Tatyana Ionova, Elena Ado, et al. · Blood

902P Quality of life and response to treatment with ixazomib-lenalidomide-dexamethasone (IRd) in patients with relapsed/refractory multiple myeloma (RRMM) in a real-world setting

2020 · T. Ionova, L. Anchukova, et al. · Annals of Oncology

The Results of the Russian Registry of Primary Immune Thrombocytopenia (ITP) in Adults

2015 · Igor Lisukov, Alexey Maschan, et al. · Blood

Открытое многоцентровое исследование деферазирокса в лечении посттрансфузионной перегрузки железом у пациентов с миелодиспластическими синдромами, талассемией и другими формами анемий

2015 · Savchenko Vg, Abdulkadyrov Km, et al. · Гематология и трансфузиология

Современные методы диагностики и лечения пароксизмальной ночной гемоглобинурии

2012 · А. В. Костерина, А. Р. Ахмадеев, et al. · Practical medicine

Works count: 16

Citation count: 18

H-index: 3

I10-index: